HCC patients with MCGs mutations had significantly higher expression levels of tumor-related genes, including MET, TP53, ARID1A, and TTN (Figure 1E), while no significant differences were found among patients divided by SCNA status (Figure 1F). This evidence concerns the gene TTN and neoplasm.